Pediatric Growth Hormone Deficiency Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

By Type (Congenital GH Deficiency, Acquired GH Deficiency, Idiopathic GH Deficiency), By Product (Powder, Solvent), By Application (Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader-Willi Syndrome, Others), By Drug (Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader-Willi Syndrome, Others), By Distribution Channel (Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader-Willi Syndrome, Others), By Region & Competition

Published	Pages	Publisher	Report code
Oct 2023	175	TechSci Research	ASDR-637878

Published: Oct 2023 - Pages : 175 - Publisher : TechSci Research - Report code : ASDR-637878

1. Novo Nordisk A/S
2. Eli Lily and Company
3. Novartis AG
4. Merck KgaA
5. Pfizer Inc.
6. Ferring B.V
7. Genentech Inc
8. BioParteners GmbH
9. LG Chem Ltd.
10. Ipsen Pharma

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2021

This report can be of interest as well:

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2021

Published: February, 2021 | Report code: ASDR-572809